🌐 NEWS: Curebase raises its $15M Series A led by GGV Capital. Read about it in Crunchbase, FierceBiotech, and MedCity News.
At Curebase we are rapidly expanding and preparing for the wave of decentralization in clinical trials that we intend to lead. To that end we have recently hired a Director of Clinical Operations, Adam Samson...
At Curebase, we believe that clinical trials can be transformed to include every patient and physician in the research process, regardless of geography. That mindset is all the more important now that traditiona
.png)
Curebase is announcing the launch of CURE-19, a dedicated platform for running at-home COVID-19 clinical trials. Via CURE-19, any patient in the United States, no matter where they live, can sign up for the plat
At Curebase we are rapidly expanding and preparing for the wave of decentralization in clinical trials that we intend to lead. To that end we have recently hired a Director of Clinical Operations, Adam Samson...
At Curebase we are rapidly expanding and preparing for the wave of decentralization in clinical trials that we intend to lead. To that end we have recently hired a Director of Clinical Operations, Adam Samson...
